Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Culture Zone: Europe.
Press releases published on May 7, 2025

Arla Foods Ingredients showcases protein soda concept at Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Consumers are …

Arla Foods Ingredients menampilkan konsep soda protein di Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients akan menyoroti manfaat fungsional dari pure BLG (beta-laktoglobulin) dalam konsep soda protein baru di Vitafoods Europe. Konsep soda protein Arla Foods Ingredients Konsumen semakin …

Europe Arla Foods Ingredients นำเสนอแนวคิดโซดาโปรตีน ที่งาน Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients จะเน้นคุณประโยชน์เชิงฟังก์ชันของ pure BLG (เบต้า-แลคโตโกลบูลิน) ในแนวคิดโซดาโปรตีนใหม่ที่งาน Vitafoods Europe แนวคิดโซดาโปรตีน Arla Foods Ingredients …

Arla Foods Ingredients mempersembahkan konsep soda protein di Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients akan menonjolkan manfaat fungsional pure BLG (beta-laktoglobulin) dalam konsep soda protein baru di Vitafoods Europe. Konsep Soda Protein Arla Foods Ingredients Pengguna kini semakin …

Arla Foods Ingredients giới thiệu ý tưởng soda protein tại Vitafoods Europe
AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients sẽ làm nổi bật lợi ích chức năng của pure BLG (beta-lactoglobulin) trong ý tưởng soda protein mới tại Vitafoods Europe. Ý tưởng soda protein của Arla Foods Ingredients Người tiêu dùng …

Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference
Optigo wins People’s Choice Award at the recent Eyecelerator meeting in Park City for proprietary drug anchoring, potential to transform intravitreal drug delivery Preclinical data demonstrates sustained efficacy and safety for six months or more following …